npj Vaccines (Mar 2024)

Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics

  • Sara Terzoli,
  • Paolo Marzano,
  • Valentina Cazzetta,
  • Rocco Piazza,
  • Inga Sandrock,
  • Sarina Ravens,
  • Likai Tan,
  • Immo Prinz,
  • Simone Balin,
  • Michela Calvi,
  • Anna Carletti,
  • Assunta Cancellara,
  • Nicolò Coianiz,
  • Sara Franzese,
  • Alessandro Frigo,
  • Antonio Voza,
  • Francesca Calcaterra,
  • Clara Di Vito,
  • Silvia Della Bella,
  • Joanna Mikulak,
  • Domenico Mavilio

DOI
https://doi.org/10.1038/s41541-024-00853-9
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 16

Abstract

Read online

Abstract γδ T cells provide rapid cellular immunity against pathogens. Here, we conducted matched single-cell RNA-sequencing and γδ-TCR-sequencing to delineate the molecular changes in γδ T cells during a longitudinal study following mRNA SARS-CoV-2 vaccination. While the first dose of vaccine primes Vδ2 T cells, it is the second administration that significantly boosts their immune response. Specifically, the second vaccination uncovers memory features of Vδ2 T cells, shaped by the induction of AP-1 family transcription factors and characterized by a convergent central memory signature, clonal expansion, and an enhanced effector potential. This temporally distinct effector response of Vδ2 T cells was also confirmed in vitro upon stimulation with SARS-CoV-2 spike-peptides. Indeed, the second challenge triggers a significantly higher production of IFNγ by Vδ2 T cells. Collectively, our findings suggest that mRNA SARS-CoV-2 vaccination might benefit from the establishment of long-lasting central memory Vδ2 T cells to confer protection against SARS-CoV-2 infection.